SSR1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.821200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.654200E-01
Normal-vs-Stage2
6.165200E-01
Normal-vs-Stage3
2.108400E-01
Normal-vs-Stage4
3.796200E-01
Stage1-vs-Stage2
6.275600E-01
Stage1-vs-Stage3
2.297400E-01
Stage1-vs-Stage4
2.981400E-01
Stage2-vs-Stage3
4.089800E-01
Stage2-vs-Stage4
1.710770E-01
Stage3-vs-Stage4
3.904500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.817600E-01
Normal-vs-AfricanAmerican
5.953000E-01
Normal-vs-Asian
1.866780E-01
Caucasian-vs-AfricanAmerican
2.267400E-01
Caucasian-vs-Asian
1.113390E-01
AfricanAmerican-vs-Asian
3.342200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.259000E-01
Normal-vs-Female
7.217800E-01
Male-vs-Female
8.866400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.776450E-01
Normal-vs-Age(41-60Yrs)
9.326600E-01
Normal-vs-Age(61-80Yrs)
6.151600E-01
Normal-vs-Age(81-100Yrs)
7.809000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.737200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.395400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.758600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.568200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.925400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.486800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.816200E-01
Normal-vs-Daily Drinker
1.089990E-01
Normal-vs-Weekly Drinker
6.601000E-01
Normal-vs-Occasional Drinker
8.218200E-01
Normal-vs-Social Drinker
9.574400E-01
Non Drinker-vs-Daily Drinker
2.603200E-01
Non Drinker-vs-Weekly Drinker
3.159400E-01
Non Drinker-vs-Occasional Drinker
1.648570E-01
Non Drinker-vs-Social Drinker
1.217780E-01
Daily Drinker-vs-Weekly Drinker
6.912000E-02
Daily Drinker-vs-Occasional Drinker
7.810100E-02
Daily Drinker-vs-Social Drinker
3.087600E-02
Weekly Drinker-vs-Occasional Drinker
3.631400E-01
Weekly Drinker-vs-Social Drinker
6.094600E-01
Occasional Drinker-vs-Social Drinker
5.785600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.054200E-01
Normal-vs-Grade 2
7.179000E-01
Normal-vs-Grade 3
3.343000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.116200E-01
Grade 1-vs-Grade 3
1.952360E-01
Grade 1-vs-Grade 4
4.054200E-01
Grade 2-vs-Grade 3
8.432400E-01
Grade 2-vs-Grade 4
7.179000E-01
Grade 3-vs-Grade 4
3.343000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.986800E-01
Normal-vs-NonDiabetic
5.604400E-01
Diabetic-vs-NonDiabetic
8.667600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.466200E-02
Normal-vs-NoPancreatitis
7.633000E-01
Pancreatitis-vs-NoPancreatitis
6.459300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.359600E-01
Normal-vs-N1
6.352000E-01
N0-vs-N1
4.523400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.353800E-01
Normal-vs-TP53-NonMutant
8.720000E-01
TP53-Mutant-vs-TP53-NonMutant
5.899600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
